Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: Results of a prospective study

Bone Marrow Transplantation

Volumn 34, Issue 8, 2004, Pages 729-738

  Diez Campelo M ^a   Perez Simon J A ^a   Gonzalez Porras J R ^a   Garcia Cecilia J M ^b   Salinero, M ^a   Caballero, M D ^a   Canizo M C ^a   Ocio, E M ^a   San Miguel, J F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b Faculty of Psychology   (Spain)

Author keywords

Allogeneic transplant; Nonmyeloablative; QOL; Quality of life; Reduced intensity conditioning

Indexed keywords

BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MELPHALAN; METHOTREXATE; THIOTEPA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMYLOIDOSIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER MORTALITY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FUNCTIONAL ASSESSMENT; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM; SELF REPORT; SOCIAL ASPECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; HUMANS; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 6444225880     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704646     Document Type: Article

References (44)

1. Woolf SH. Shared decision making: the case for letting patients decide which choice is best. J Fam Pract 1997; 45: 205-208.
2. Silver RT, Woolf SH, Hehlmann R et al. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukaemia: developed for the American Society of Haematology. Blood 1999; 5: 1517 -1536.
3. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acure myelogenous leukaemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217-223.
4. Sebban C, Lepage E, Vernant JP et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukaemia in first complete remission: a comparative study. French group of therapy of adult acute lymphoblastic leukaemia. J Clin Oncol 1994; 12: 2580-2587.
5. Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 18 1290-1298.
6. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 23: 1540-1545.
7. Worel N, Biener D, Kalhs P et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619-626.
8. Chao N J, Tierney K, Bloom JR et al. Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 1992; 80: 825-830.
9. Hjermstad M J, Evensen SA, Kvaloy SO et al. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol 1999; 17: 706-718.
10. Heinonem H, Volin L, Uutela A et al. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 2001; 80: 137-143.
11. Kiss TL, Abdolell M, Jamal N et al. Long-term medical outcomes and quality of life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002; 20: 2334-2343.
12. Neitzert CS, Ritvo P, Dancey J et al. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant 1998; 22: 409-422.
13. Kopp M, Schweigkofler H, Holzner B et al. Time alter bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality of life assessment. Ann Hematol 1998; 77 27-32.
14. Syrjala KL, Chapko MK, Vitaliano PP et al. Recovery alter allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319-327.
15. Zittoun R, Suciu S, Watson M et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission alter bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of EORTC-GIMEMA AML 84 trial. Bone Marrow Transplant 1997; 20: 307-315.
16. Andrykowski MA, Henslee-Downey P J, Farral MG. Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 75-81.
17. Belec RH. Quality of life: perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum 1992; 19: 31-37.
18. Jenkins PL, Linington A, Whittaker JA. A retrospective study of psychosocial morbidity in bone marrow transplantation recipients. Psychosomatics 1991; 32: 65-71.
19. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cito-reduction for the treatment of malignant and non malignant hematologic diseases. Blood 1998; 91: 756-763.
20. Martino R, Caballero MD, Canals C et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicenter study. Br J Haematol 2001; 115: 653-659.
21. Slevin ML, Plant H, Lynch D et al. Who should measure quality of life, the doctor or the patient? Br J Cancer 1998; 57 109-112.
22. Aaronson NK, Ahmedzai S, Bergman B et al. The European organization for research and treatment of cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
23. Kopp M, Schweigkofler H, Holzner B et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Hematol 2000; 65: 97-103.
24. Cella DF, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
25. McQuellon RP, Russell GB, Cella DF et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357-368.
26. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
27. Caballero MD, Rubio V, Rifón J et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 1997; 20: 451-458.
28. Sureda A, Arranz R, Iriondo A et al. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol 2001; 19: 1395-1404.
29. Caballero MD, Perez-Simon JA, Iriondo A et al. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 2003; 14: 140-151.
30. Arnau J. Diseños longitudinales aplicados a las CC. SS. y del comportamiento. Limusa: México, 1995.
31. Kirk RE. Experimental Design. Procedures for the Behaviorial Sciences, (2nd edn) Brooks/Cole: Monterrey, 1982.
32. Maxwell SE, y Delaney HD. Designing Experiments and Analysis of Data - A Model Comparison Perspective. Wadsworth Publishing Company: Beltmont, 1990.
33. Armitage JO. Bone Marrow Transplantation. N Eng J Med 1994; 330: 827-838.
34. Klingemann HG, Storb R, Fefer A et al. Bone marrow transplantation in patients aged 45 years and older. Blood 1986; 65: 770-776.
35. Chiodi S, Spinelli S, Ravera G et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614-619.
36. Hjermstad JR, Kaasa S. Quality of life in adult cancer patients treated with bone marrow transplantation - a review of the literature. Eur J Cancer Care 1995; 31A: 163-173.
37. Pérez-Simón JA, Martino R, Alegre A et al. Chronic but not acure graft versus host disease improves outcome in multiple myeloma patients after nonmyeloablative allogeneic transplantation. Br J Hematol 2003; 121: 104-108.
38. Vickberg S, Duhamel KN, Smith MY et al. Global meaning and psychological adjustment among survivors of bone marrow transplant. Psycho-oncology 2001; 10: 29-39.
39. Andrykowski MA, Greiner CB, Altmaier EM et al. Quality of life following bone marrow transplantation: findings from a multicenter study. Br J Cancer 1995; 71: 1322-1329.
40. Andrykowski MA, Carpenter JS, Greiner CB et al. Energy levei and sleep quality following bone marrow transplantation. Bone Marrow Transplant 1997; 20: 669-679.
41. Hann DM, Jacobsen PB, Martin SC et al. Quality of life following bone marrow transplantation for breast cancer: a comparative study. Bone Marrow Transplant 1997; 19: 257-264.
42. Whedon M, Stearns D, Millis LE. Quality of life of long-term adult survivors of autologous bone marrow transplantation. Oncol Nursing Forum 1995; 22: 1322-1329.
43. McQuellon RP, Craven B, Russell GB et al. Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant 1996; 18: 579-584.
44. Syrjala KL, Chapko MK, Vitaliano PP et al. Recovering after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319-327.